F. Trudzinski (Homburg/Saar, Germany), M. Held (Wuerzburg, Germany), F. Franssen (Horn, Netherlands), E. Mekov (Sofia, Bulgaria)
Development of a COPD model of care in a rural District General Hospital in Highland Scotland L. Murray (London, United Kingdom)
| |
Adherence to inhaled therapies in COPD patients from 7 Latin America countries: the LASSYC study M. Montes De Oca (Caracas, Venezuela)
| |
Simulated-use study of inhaler usability in patients with COPD B. Ding (Mölndal, Sweden)
| |
Misuse of inhalers devices in clinical practice A. Silva Duarte De Araújo (Braga, Portugal)
| |
Understanding patient’ adherence to inhaled medication: the social representations of COPD A. Silva Duarte De Araújo (Braga, Portugal)
| |
Clinical audit of COPD in outpatient respiratory clinics in Spain. Effect of specialized COPD clinics and general respiratory clinics: the EPOCONSUL study G. Vargas Centanaro (MADRID, Spain)
| |
Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine). R. Dal Negro (Verona, Vr, Italy)
| |
Association of COPD inhaled medication adherence with hospitalization for acute exacerbation of COPD (AECOPD) M. Moretti (Modena, Italy)
| |
Inhaled corticosteroids in stable COPD – international recommendations and reality in Bulgaria B. Stancheva (SOFIA, Bulgaria)
| |
Chinese subgroup results from a study comparing single-inhaler triple therapy with dual therapy in COPD d. Xin
| |
Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy D. Singh (Manchester, United Kingdom)
| |
Degree of control in COPD patients at Primary Care and Pulmonology clinics: Study SINCON J. Rodriguez Glez-Moro (Alcalá de Henares, Spain)
| |
Effect of olodaterol once-daily on heart rate in GOLD 2–4 COPD patients S. Andreas (Immenhausen, Germany)
| |
Treatment of COPD Exacerbation in Switzerland - results and recommendations of the European COPD Audit D. Schumann (Basel, Switzerland)
| |
LABA/LAMA combination, exercise and lung hyperinflation in COPD: a meta-analysis M. Cazzola (Roma, Rm, Italy)
| |
Oxygen compared to air driven nebulisers for acute exacerbations of COPD: a randomised controlled trial. G. Bardsley (Hornsea, United Kingdom)
| |
Erdosteine is effective as a treatment for acute exacerbation of COPD: a systematic review of clinical trials M. Moretti (Modena, Italy)
| |
E-health technologies in pneumonia and COPD patients mortality decreasing V. Mishlanov (Perm, Russian Federation)
| |
ACTIVATE: effect of aclidinium/formoterol on physical activity in patients with COPD H. Watz (Großhansdorf, Germany)
| |